These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36346134)

  • 1. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
    Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
    Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
    Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
    Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Neurofascin autoimmune nodopathy - a life-threatening, but reversible neuropathy.
    Appeltshauser L; Doppler K
    Curr Opin Neurol; 2023 Oct; 36(5):394-401. PubMed ID: 37639464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
    Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different binding and pathogenic effect of neurofascin and contactin-1 autoantibodies in autoimmune nodopathies.
    Hecker K; Grüner J; Hartmannsberger B; Appeltshauser L; Villmann C; Sommer C; Doppler K
    Front Immunol; 2023; 14():1189734. PubMed ID: 37388725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neurofascin autoantibody and demyelination.
    Kira JI; Yamasaki R; Ogata H
    Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing Spectrum of Autoimmune Nodopathies.
    Gupta P; Mirman I; Shahar S; Dubey D
    Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
    Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy.
    Stengel H; Vural A; Brunder AM; Heinius A; Appeltshauser L; Fiebig B; Giese F; Dresel C; Papagianni A; Birklein F; Weis J; Huchtemann T; Schmidt C; Körtvelyessy P; Villmann C; Meinl E; Sommer C; Leypoldt F; Doppler K
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies.
    Appeltshauser L; Messinger J; Starz K; Heinrich D; Brunder AM; Stengel H; Fiebig B; Ayzenberg I; Birklein F; Dresel C; Dorst J; Dvorak F; Grimm A; Joerk A; Leypoldt F; Mäurer M; Merl P; Michels S; Pitarokoili K; Rosenfeldt M; Sperfeld AD; Weihrauch M; Welte GS; Sommer C; Doppler K
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35314491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of monovalency on anti-contactin-1 IgG4.
    Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
    Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
    Doppler K; Appeltshauser L; Villmann C; Martin C; Peles E; Krämer HH; Haarmann A; Buttmann M; Sommer C
    Brain; 2016 Oct; 139(Pt 10):2617-2630. PubMed ID: 27474220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune nodopathies, an emerging diagnostic category.
    Martín-Aguilar L; Lleixà C; Pascual-Goñi E
    Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model.
    Doppler K; Schuster Y; Appeltshauser L; Biko L; Villmann C; Weishaupt A; Werner C; Sommer C
    J Neuroinflammation; 2019 Apr; 16(1):73. PubMed ID: 30953561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4 Valency Modulates the Pathogenicity of Anti-Neurofascin-155 IgG4 in Autoimmune Nodopathy.
    Jentzer A; Attal A; Roué C; Raymond J; Lleixà C; Illa I; Querol L; Taieb G; Devaux J;
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35948442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies.
    Dalakas MC
    Neurotherapeutics; 2022 Apr; 19(3):741-752. PubMed ID: 35290608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG
    Fehmi J; Davies AJ; Walters J; Lavin T; Keh R; Rossor AM; Munteanu T; Delanty N; Roberts R; Bäumer D; Lennox G; Rinaldi S
    J Neurol Neurosurg Psychiatry; 2021 Oct; 92(10):1089-1095. PubMed ID: 34400540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
    Moodley K; Patel VB; Moodley AA; Bill PLA; Kajee A; Mgbachi V; Fehmi J; Rinaldi S
    J Peripher Nerv Syst; 2023 Dec; 28(4):578-585. PubMed ID: 37676746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy.
    Kmezic I; Press R; Glenewinkel H; Doppler K; Appeltshauser L
    J Neuroimmunol; 2024 Apr; 389():578326. PubMed ID: 38422690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.